Red Light Therapy for Endometriosis: Could It Help With Pain?

Living with endometriosis often means looking for ways to make everyday life more manageable. Pain can interrupt work, exercise, sex and sleep, while finding the right treatment can take time.

Red light therapy attracts interest because it can influence processes involved in pain, inflammation and tissue repair. Some of these applications have been studied more thoroughly than endometriosis itself.

Understanding the difference between relieving symptoms and treating the underlying disease helps put that research into perspective.

What is endometriosis?

Endometriosis is a condition in which tissue similar to the lining of the uterus grows outside it. This can cause inflammation and scar tissue, commonly around the ovaries and other pelvic structures.

The World Health Organization estimates that it affects around one in ten women of reproductive age worldwide. Symptoms vary, but can include painful periods, persistent pelvic pain, pain during sex, bowel or bladder symptoms and difficulty becoming pregnant. (WHO)

Pain is not necessarily limited to menstruation. Some people also experience lower-back discomfort, fatigue and symptoms that affect their mood or relationships. If these problems interfere with daily life, or treatment is not helping, speak to your doctor. (NHS)

Why researchers are interested in red light

Red light therapy uses visible red light, often combined with near-infrared light, which is invisible to the eye. This approach is also called photobiomodulation, meaning the use of light to influence biological activity.

Research suggests that light can affect mitochondria, the energy-producing structures inside cells, and alter signals involved in inflammation, repair and pain. Much of the detailed mechanism research comes from cells and animal models. Responses depend on the tissue, its condition and the amount of light delivered. (Hamblin, 2017)

For endometriosis, the potential attraction is not simply “more cellular energy”. Researchers need to establish whether a particular treatment reduces relevant pain or inflammation without unwanted effects.

There is also a practical question: does enough light reach the intended tissue? An external panel shining onto the abdomen delivers light very differently from a clinical device placed close to pelvic tissues.

What does research involving endometriosis show?

A small trial using a clinical high-intensity laser

A 2018 trial included 40 women with mild or moderate endometriosis, with 20 in each group. For eight weeks, one group received pulsed high-intensity laser treatment three times a week, while the other received sham treatment on the same schedule. Both groups continued their usual hormonal treatment.

The researchers reported better pain and quality-of-life outcomes with the active laser treatment. This is a useful positive signal because the trial included a comparison group.

However, it tested a specific clinical laser protocol, not a consumer LED panel. It also studied laser treatment alongside hormones, so it does not support replacing hormonal treatment with red light. (Thabet and Alshehri, 2018)

Early research on chronic pelvic pain

A separate pilot study examined light treatment delivered through a vaginal probe in women with chronic pelvic pain.

Thirteen women completed treatment, and ten were followed for six months. The authors reported that 60% met their improvement criterion; mean pain scores fell from 19.7 at baseline to 8.2 at six months among those observed. These are encouraging early results.

This study included pelvic pain from different causes rather than an endometriosis-only group. It also lacked a sham-treatment comparison, and the authors disclosed commercial relationships with the device company. The findings are encouraging, but need confirmation in independent controlled studies. (Zipper, Pryor and Lamvu, 2021)

Where the evidence stands

The evidence includes plausible mechanisms, early pelvic-pain findings and a small endometriosis trial using a different type of clinical device.

What remains uncertain is whether an external home panel provides meaningful, lasting relief from endometriosis symptoms, and which settings would achieve that.

A registered trial designed specifically to test transvaginal treatment in endometriosis was terminated because the study site lacked the resources to conduct it. No results were posted. That is a research gap, not a finding that the treatment succeeded or failed. (ClinicalTrials.gov: NCT05540353)

Indirect pathways that may be relevant

An additional treatment can be useful without removing the underlying disease. For endometriosis, the most relevant possibilities involve menstrual pain, pelvic muscle discomfort and recovery of surgical skin wounds.

Research in these neighbouring areas helps identify worthwhile questions. It does not automatically establish the same benefits in endometriosis.

1. Reducing menstrual pain

Light therapy has been studied in primary dysmenorrhoea, meaning painful periods without an identified underlying pelvic condition.

In a South Korean trial, 88 women were assigned to a small skin-adhesive light device or a dummy device. The active-treatment group experienced a greater reduction in menstrual pain. This supports a potential pain-relieving effect under the tested conditions. (Hong et al., 2016)

Another trial compared a red-light device with a combined contraceptive pill. Both groups improved, but the pill produced a larger average reduction in pain. Women with endometriosis were excluded. The results therefore support research into menstrual pain, not claims that red light equals hormonal treatment for endometriosis. (Zhu et al., 2022)

The possible indirect benefit is fewer or less intense cramps. Whether this carries over to pain caused by endometriosis needs direct testing.

2. Addressing pelvic muscle pain

Pelvic pain can have more than one source. Alongside endometriosis, some people develop painful, overactive pelvic floor muscles. Treating this muscular component may be relevant even when the endometriosis itself requires separate care.

The early vaginal-probe study offers a reason to investigate light therapy for this purpose. More rigorous research, however, gives a mixed picture.

A trial involving 103 women with pelvic floor muscle pain compared vaginal stretching plus active light therapy with stretching plus sham light. Painful intercourse improved in both groups, without establishing a clear additional benefit from the light treatment. (Frederice et al., 2022)

There are also positive findings in another distinct condition. A 2025 trial involving 30 people with pain around the vaginal opening found greater improvements in several pain measures with active light than sham treatment. It did not demonstrate better sexual function or psychological outcomes. This was specialised treatment for vulvar pain, not endometriosis or home abdominal-panel use. (Antonio, Pukall and McLean, 2025)

The practical takeaway is to identify which tissues are contributing to pain. A pelvic-health assessment can help determine whether muscular or vulvar symptoms need their own treatment.

3. Supporting recovery of surgical skin wounds

Wound healing is a more developed research area for photobiomodulation than home treatment of endometriosis.

As a related skin-injury example, a 2026 trial of 104 women after caesarean birth reported less pain after the second clinical laser session and better early wound-assessment scores than standard care alone. (Quirino de Melo Trindade et al., 2026)

This encouraging finding suggests a potential supporting role for external surgical wounds, although it does not establish benefits for endometriosis lesions or internal healing.

After endometriosis surgery, ask your surgeon whether and when light treatment is appropriate.

Why the type of device matters

Several very different technologies appear in this research:

• Home LED panels illuminate an external area of skin.
• Skin-adhesive light devices deliver a defined exposure to small locations.
• Transvaginal devices place a specialised light source closer to pelvic tissues.
• High-intensity clinical lasers use different power and delivery methods from a home panel.

These approaches cannot be treated as interchangeable.

Some studies use red or near-infrared wavelengths within ranges also found in consumer devices. That makes them relevant to the wider field, but matching a wavelength does not reproduce a study. Distance, exposure, treatment area and the route through tissue all matter.

In particular, deeper penetration does not mean that an effective dose automatically reaches every endometriosis lesion. A stronger panel or longer session is not a reliable solution to that uncertainty.

What symptom relief would, and would not, mean

Less pain would be a worthwhile outcome. It would not, by itself, show that lesions had shrunk, fertility had improved or the disease had stopped progressing.

Two commonly cited research areas need particular care:

Endometritis is not endometriosis. A study of intravascular laser treatment examined chronic endometritis, inflammation of the uterine lining. It cannot establish that light therapy treats endometriosis outside the uterus. (Konoplya et al., 2016)

Growing uterine-lining cells is not the same as treating lesions. Laboratory research has shown that light can increase the growth and activity of cultured endometrial cells. That study concerned impaired uterine-lining function. It did not demonstrate treatment of endometriosis or improved pregnancy outcomes. (El Faham et al., 2018)

Similarly, proposed effects on the vaginal microbiome remain a research topic, not an established reason to use a panel for endometriosis or vaginal infections. (Santos et al., 2023)

Keeping established care at the centre

Endometriosis treatment should reflect your symptoms, preferences, previous treatment response and whether you want to become pregnant.

Options can include pain relief, hormonal treatment, surgery and fertility care. Guidelines recommend discussing the benefits and drawbacks of these choices with your clinician. Support for quality of life and psychological well-being also matters. (ESHRE endometriosis guideline)

If pain remains difficult to manage, a specialist service may help reassess its causes and your treatment options. A panel should not delay that assessment.

The same applies to ongoing fatigue or low mood. These deserve attention in their own right, rather than an assumption that all symptoms will improve through one intervention. (NHS)

Considering a home panel

If your clinician agrees that trying an external panel is reasonable, approach it as an optional addition to your existing care.

1. Check the exact device instructions. Follow the recommended distance, session length and eye protection.
2. Keep prescribed treatment in place. Discuss medication changes with your clinician.
3. Track a few meaningful outcomes. Note pain, comfortable activity, sleep disruption and any use of rescue medication.
4. Record where you are in your cycle. Comparing similar cycle days helps avoid mistaking normal fluctuations for a treatment effect.
5. Agree on a review point. Several weeks of consistent observation may help you judge comfort, but worsening symptoms should be reviewed sooner.

There is no established home-panel dosing schedule for endometriosis. Study protocols involving vaginal probes or clinical lasers should not be copied onto a consumer device.

You can compare the specifications of Nuvibody red light therapy devices or ask customer support for the relevant manual. Product guidance explains how to operate a device; your clinician assesses whether using it makes sense for your health.

Safety and when to seek help

Red light therapy is not risk-free. Temporary skin irritation or discomfort can occur, and incorrect use can increase risks. Follow eye-protection instructions and discuss medicines or conditions that cause light sensitivity before starting. (American Academy of Dermatology)

Obtain individual medical advice if you are pregnant, could be pregnant, undergoing fertility treatment, recovering from surgery, or have active cancer or an unexplained lesion in the treatment area.

Do not use an external panel internally or improvise a vaginal treatment. Stop if exposure causes burning, persistent irritation or worsening pain. Open, weeping or infected-looking surgical wounds need medical assessment.

Seek urgent medical care for new severe or worsening pelvic pain, fainting, heavy bleeding or difficulty breathing. Pelvic pain with possible pregnancy, fever or unusual discharge also needs prompt assessment. Do not assume that every new pain is an endometriosis flare. (NHS: pelvic pain warning signs)

Frequently asked questions

Can red light therapy help endometriosis pain?

There are encouraging findings from related pain research and a small endometriosis trial using a clinical high-intensity laser. Home LED panels remain an unconfirmed option for endometriosis-specific pain. If considered, they should sit alongside appropriate medical care.

Is red light therapy as effective as the contraceptive pill?

That has not been established for endometriosis. In a study of primary menstrual pain, both treatments helped, but the pill produced a larger average pain reduction. That study excluded women with endometriosis. (Zhu et al., 2022)

Can it improve fertility?

Research on uterine-lining cells and early fertility reports does not establish that a panel improves the chance of pregnancy in someone with endometriosis. Discuss fertility goals with your gynaecologist, since they can change which treatments are appropriate. (ESHRE guideline)

Can I use it after endometriosis surgery?

Ask your surgeon first. Findings from other surgical wounds support investigation, but do not establish the right timing or treatment for your operation. Continue the wound-care and recovery instructions you have been given.

Is red light therapy the same as a heating pad?

No. A heating pad works through warmth. Photobiomodulation aims to influence tissue through light absorption, although a device may also feel warm. Feeling heat does not tell you whether an effective light dose has reached the intended tissue.

Sources

• WHO. Endometriosis: overview, symptoms and treatment.
• Thabet and Alshehri, 2018. High-intensity laser trial in women with endometriosis.
• Zipper, Pryor and Lamvu, 2021. Pilot study of transvaginal photobiomodulation for chronic pelvic pain.
• Hong et al., 2016. Placebo-controlled trial of a skin-adhesive light device for menstrual pain.
• Zhu et al., 2022. Comparison of red-light treatment and oral contraception for primary dysmenorrhoea.
• Frederice et al., 2022. Vaginal stretching with active or sham light therapy.
• Antonio, Pukall and McLean, 2025. Placebo-controlled light-therapy trial for vulvar pain.
• Quirino de Melo Trindade et al., 2026. Clinical laser treatment after caesarean birth.
• Hamblin, 2017. Review of photobiomodulation and inflammation.
• Konoplya et al., 2016. Intravascular laser research in chronic endometritis.
• El Faham et al., 2018. Laboratory research on endometrial cells.
• Santos et al., 2023. Review of proposed effects on the vaginal microbiome.
• ClinicalTrials.gov. Endometriosis trial NCT05540353.
• ESHRE. Endometriosis guideline.
• NHS: Endometriosis and pelvic pain warning signs.
• American Academy of Dermatology. Red light therapy safety.

This article provides general information, not a diagnosis or individual treatment advice. Consult a qualified healthcare professional about endometriosis and before changing your treatment.